S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
SWOG Cancer Research Network
SWOG Cancer Research Network
University of Chicago
Allogene Therapeutics
Gilead Sciences
University of Arizona
Thomas Jefferson University
Universität des Saarlandes
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
University of Liverpool
Fred Hutchinson Cancer Center
Mayo Clinic
University of Giessen
City of Hope Medical Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
National Cancer Institute (NCI)
University of Nebraska
Masonic Cancer Center, University of Minnesota
University of Nebraska
M.D. Anderson Cancer Center
TCR2 Therapeutics
Thomas Jefferson University
Fondazione Italiana Linfomi - ETS
Roswell Park Cancer Institute
Universität des Saarlandes
City of Hope Medical Center
Hoffmann-La Roche
Universität des Saarlandes
Universität des Saarlandes
Universität des Saarlandes
European Organisation for Research and Treatment of Cancer - EORTC
SWOG Cancer Research Network
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Washington
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Celgene
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
SWOG Cancer Research Network
Mayo Clinic
Case Comprehensive Cancer Center